27 States Sue To Block Sale Of 23andMe Genetic Data

June 11, 2025 Business, Science

Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks the court’s approval to buy the struggling firm.

Biological samples, DNA data, health-related traits and medical records are too sensitive to be sold without each person’s express, informed consent, Oregon Attorney General Dan Rayfield said.

Regeneron Pharmaceuticals said last month it aimed to buy the company for $256 million. Regeneron said it would comply with 23andMe’s privacy policies and applicable law.

Read the full article.

Twenty-seven states and the District of Columbia on Monday filed a lawsuit seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks approval to buy the struggling firm. https://t.co/43nXOt7N5K

— ABC News (@ABC) June 10, 2025